Brachytherapy, a standard of care for some cancer indications, which involves delivering radiotherapy from a source within the tumour, is underfunded, increasingly marginalised and in decline across much of Europe. Janet Fricker talked to specialists [more]
When we talk about advances in cancer care patient advocacy groups tend to focus on the development of new drugs, immunotherapy being the latest flavour. This is encouraged by the pharma industry, keen to gain [more]
Sriram Venneti and colleagues examine non-invasive metabolic imaging strategies that can be used to interrogate some of the genomic alterations in brain tumours, with the ultimate goal of informing patient management. This is an abridged [more]
Molecular imaging specialists are ready to break out of their research huddles and take their place at the heart of clinical decision making. But can they convince clinicians to welcome them in? Anna Wagstaff investigates. [more]
Imaging techniques used in staging and evaluation of response to treatment have improved dramatically over the past 120 years. The issue going forward will be learning to combine anatomical and functional imaging modalities to get [more]